Microbot Medical Inc [NASDAQ: MBOT] price surged by 8.05 percent to reach at $0.31.
A sum of 11182702 shares traded at recent session while its average daily volume was at 1.95M shares. Microbot Medical Inc shares reached a high of $4.62 and dropped to a low of $3.9 until finishing in the latest session at $4.16.
The one-year MBOT stock forecast points to a potential upside of 53.78. The average equity rating for MBOT stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Microbot Medical Inc [MBOT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MBOT shares is $9.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MBOT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Microbot Medical Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 13, 2020. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price from $10 to $12. The new note on the price target was released on December 24, 2019, representing the official price target for Microbot Medical Inc stock. Previously, the target price had yet another raise to $1.75, while Ladenburg Thalmann analysts kept a Buy rating on MBOT stock.
The Price to Book ratio for the last quarter was 5.20, with the Price to Cash per share for the same quarter was set at 0.72.
MBOT Stock Performance Analysis:
Microbot Medical Inc [MBOT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 35.06. With this latest performance, MBOT shares gained by 40.07% in over the last four-week period, additionally plugging by 166.67% over the last 6 months – not to mention a rise of 271.43% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MBOT stock in for the last two-week period is set at 80.41, with the RSI for the last a single of trading hit 0.32, and the three-weeks RSI is set at 0.25 for Microbot Medical Inc [MBOT]. The present Moving Average for the last 50 days of trading for this stock 2.75, while it was recorded at 3.59 for the last single week of trading, and 2.02 for the last 200 days.
Microbot Medical Inc (MBOT) Capital Structure & Debt Analysis
According to recent financial data for Microbot Medical Inc. ( MBOT), the Return on Equity (ROE) stands at -69.80%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -62.65%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Microbot Medical Inc’s Return on Invested Capital (ROIC) is -41.80%, showcasing its effectiveness in deploying capital for earnings.
Microbot Medical Inc (MBOT) Efficiency & Liquidity Metrics
Based on Microbot Medical Inc’s (MBOT) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Microbot Medical Inc (MBOT) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Microbot Medical Inc. (MBOT) effectively leverages its workforce, generating an average of -$605238.1 per employee. The company’s liquidity position is robust, with a Current Ratio of 12.06% and a Quick Ratio of 12.06%, indicating strong ability to cover short-term liabilities.
MBOT Stock EPS
With the latest financial reports released by the company, Microbot Medical Inc posted -0.2/share EPS, while the average EPS was predicted by analysts to be reported at -0.17/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.03. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MBOT.
Microbot Medical Inc [MBOT] Institutonal Ownership Details
There are presently around $10.01%, or 10.02%% of MBOT stock, in the hands of institutional investors. The top three institutional holders of MBOT stocks are: VANGUARD GROUP INC with ownership of 0.46 million shares, which is approximately 3.0953%. BLACKROCK INC., holding 0.14 million shares of the stock with an approximate value of $$0.14 million in MBOT stocks shares; and BLACKROCK INC., currently with $$0.12 million in MBOT stock with ownership which is approximately 0.8078%.
